Country · Healthcare markets
China healthcare markets
178 reports across 5 categories, with market size and growth to 2033.
China healthcare markets178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023 · share of the world market
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Bayer AG15 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
IBM Watson Health13 reports
Each market name opens its China report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| 3D Laparoscopy Imaging Systems | $257 Mn | $566 Mn | 8.2% | 8% | 21 |
| 3D Printed Implants | $289 Mn | $1.2 Bn | 15% | 8% | 12 |
| 3D Printing in Medical Application | $193 Mn | $1.4 Bn | 21.8% | 8% | 24 |
| Artificial Intelligence (AI) in Drugs Discovery | $48 Mn | $552 Mn | 27.6% | 8% | 142 |
| Artificial Intelligence (AI) in Healthcare | – | – | – | – | 605 |
| Artificial Intelligence (AI) in Life Sciences | $177 Mn | $2.1 Bn | 28.2% | 8% | 457 |
| Artificial Intelligence (AI) in Medical Imaging | $72 Mn | $771 Mn | 26.7% | 8% | 210 |
| Artificial Intelligence (AI) in Medicine | $667 Mn | $18 Bn | 39% | – | 605 |
| Artificial Intelligence (AI) in Pharma | – | – | – | – | 142 |
| Artificial Intelligence (AI) in Radiology | $48 Mn | $670 Mn | 30.1% | 8% | 56 |
| Artificial Intelligence (AI) in Remote Patient Monitoring | $72 Mn | $1.2 Bn | 31.9% | 8% | 9 |
| Artificial Intelligence (AI) Machine Learning(ML) in Healthcare | $153 Mn | $4.3 Bn | 39.5% | 8% | 605 |
| Blockchain in Genomics | $179 Mn | $5.1 Bn | 39.8% | 8% | 1 |
| Blockchain-as-a-Service | $169 Mn | $2.5 Bn | 30.8% | 8% | 1 |
| Brain Imaging, Biomarkers and NeuroInformatics | $55 Mn | $100 Mn | 6.2% | 8% | 812 |
| Brain PET-MRI Systems | $27 Mn | $59 Mn | 8% | 8% | 237 |
| Clinical Alarm Management | $140 Mn | $224 Mn | 4.8% | 8% | 16 |
| Clinical Data Management Systems | $201 Mn | $707 Mn | 13.4% | 8% | 15 |
| Connected Healthcare Market | $4.7 Bn | $58.5 Bn | 28.6% | 8% | 35 |
| Decentralized Clinical Trials(DCTs) | $132 Mn | $597 Mn | 16.3% | 8% | 617 |
| Dental 3D Printing | $273 Mn | $2 Bn | 22% | 8% | 2 |
| Dental CAD/CAM | $267 Mn | $793 Mn | 11.5% | 8% | 8 |
| Digital Biomarkers | $354 Mn | $8.2 Bn | 37% | 8% | 81 |
| Digital diabetes care | $1 Bn | $6.8 Bn | 20.8% | 8% | 75 |
| Digital Pathology Systems | $97 Mn | $397 Mn | 15.2% | 8% | 203 |
| Digital Therapeutics | $547 Mn | $4.2 Bn | 22.5% | 8% | 367 |
| Digital Twin | $137 Mn | $1.4 Bn | 25.8% | 8% | 5 |
| Digital X-ray | $1.4 Bn | $2.8 Bn | 7.3% | 8% | 387 |
| Electronic Health Record | $2.9 Bn | $5.1 Bn | 5.7% | 8% | 165 |
| Healthcare Information System | $23.3 Bn | $128.4 Bn | 18.6% | 8% | 425 |
| Healthcare IT | $38.8 Bn | $142.5 Bn | 13.9% | 8% | 151 |
| Home Healthcare | $29.1 Bn | $71.5 Bn | 9.4% | 8% | 340 |
| Internet Of Things In Healthcare | $8 Bn | $43.7 Bn | 18.5% | 8% | 4 |
| IoT in Healthcare | $14.5 Bn | $79.9 Bn | 18.6% | 8% | 4 |
| Long-term Care Software | $281 Mn | $1.1 Bn | 14.1% | 8% | 57 |
| Mental Health Apps | $450 Mn | $3.3 Bn | 22.2% | 8% | 18 |
| Pathology Imaging Systems | $130 Mn | $458 Mn | 13.4% | 8% | 203 |
| Point of Care Diagnostics | $3.6 Bn | $8.6 Bn | 8.9% | 8% | 822 |
| Remote Medication Management | $312 Mn | $1.7 Bn | 18.5% | 8% | 63 |
| Remote Patient Monitoring | $127 Mn | $742 Mn | 19.3% | 8% | 85 |
| Werable Healthcare Devices | $2.6 Bn | $18.1 Bn | 21.3% | 8% | 121 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Alopecia areata | – | – | – | – | 21 |
| Alzheimers Dignostic | $169 Mn | $378 Mn | 8.4% | 8% | 148 |
| Ambulance Service | $2.5 Bn | $5.7 Bn | 8.6% | 8% | 91 |
| Ambulatory Surgery Center | $3.2 Bn | $6.7 Bn | 7.6% | 8% | 2,609 |
| Antimicrobial Susceptibility Testing | – | – | – | – | 24 |
| Bioinformatics | $981 Mn | $4.3 Bn | 15.9% | 8% | – |
| Biomaterial Wound Dressing | $659 Mn | $1.4 Bn | 8.2% | 8% | 25 |
| Blood Gas and Electrolyte Analyzers | $225 Mn | $482 Mn | 7.9% | 8% | 137 |
| Bone Cancer Diagnostic | $88 Mn | $207 Mn | 8.9% | 8% | 158 |
| Brain Cancer Diagnostic | $121 Mn | $492 Mn | 15.1% | 8% | 264 |
| Breast Cancer Diagnostic | $330 Mn | $802 Mn | 9.3% | 8% | 973 |
| Clinical Laboratory Service | – | – | – | – | – |
| Dental Care Service | – | – | – | – | – |
| Dental Imaging | $273 Mn | $671 Mn | 9.4% | 8% | – |
| Dermatology Diagnostic | $2.1 Bn | $6.9 Bn | 12.7% | 8% | 895 |
| Fertility Service | $1.7 Bn | $3.5 Bn | 7.6% | 8% | – |
| Healthcare Electronic Data Interchange (EDI) | $322 Mn | $905 Mn | 10.9% | 8% | 7 |
| Healthcare In Vitro Diagnostic | $6.7 Bn | $11.3 Bn | 5.3% | 8% | 39 |
| Hospitals and Health Systems | $350.2 Bn | $695.4 Bn | 7.1% | 8% | 16,458 |
| Medical Billing | $362 Mn | $1.2 Bn | 12.9% | 8% | 12 |
| Medical Tourism | $6 Bn | $21.5 Bn | 13.7% | 8% | 3 |
| Nursing Education | $828 Mn | $2.1 Bn | 9.6% | 8% | 74 |
| Patient Support Programs (PSP) | $1.4 Bn | $6.8 Bn | 17.3% | 8% | 122 |
| Point Of Care (PoC) Molecular Diagnostic | $1.5 Bn | $4.2 Bn | 10.8% | 8% | 50 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Acute Care Needleless Connectors | $39 Mn | $93 Mn | 9% | 8% | – |
| Advanced Bipolar Direct Energy Devices | $249 Mn | $658 Mn | 10.2% | 8% | – |
| Aesthetic Lasers and Energy Devices | $130 Mn | $466 Mn | 13.6% | 8% | – |
| Air Ambulance Life Support Solutions | $359 Mn | $984 Mn | 10.6% | 8% | – |
| Airway Management Devices | $161 Mn | $308 Mn | 6.7% | 8% | – |
| Anastomosis Devices | $253 Mn | $562 Mn | 8.3% | 8% | – |
| Anesthesia & Respiratory Devices | $2.3 Bn | $6.6 Bn | 11% | 8% | – |
| Anesthesia Monitoring Devices | $212 Mn | $787 Mn | 14% | 8% | – |
| Angiography Devices | $1 Bn | $2.1 Bn | 7.8% | 8% | – |
| Angioplasty Balloons | $326 Mn | $547 Mn | 5.3% | 8% | – |
| Anti-Snoring Devices | $101 Mn | $268 Mn | 10.3% | 8% | – |
| Apheresis Equipments | $204 Mn | $429 Mn | 7.7% | 8% | – |
| Arrhythmia Monitoring Devices | $483 Mn | $950 Mn | 7% | 8% | – |
| Assisted Walking Aids | $185 Mn | $364 Mn | 7% | 8% | – |
| Audiology Devices | $629 Mn | $1.3 Bn | 7.9% | 8% | – |
| Defibrillator | $1.4 Bn | $2.9 Bn | 7.4% | 8% | – |
| Dental Articulators | $31 Mn | $67 Mn | 7.9% | 8.1% | – |
| Dental Caries Detectors | $30 Mn | $104 Mn | 13.3% | 8% | – |
| Dental Diagnostic and Surgical Equipments | $963 Mn | $2.2 Bn | 8.6% | 8% | – |
| Dental X-Ray Equipments | $141 Mn | $324 Mn | 8.7% | 8% | – |
| Diabetes Care Devices | $3.4 Bn | $7 Bn | 7.4% | 8% | – |
| Digital Diabetes Management | – | – | – | – | – |
| Direct Energy Medical Devices | $888 Mn | $1.7 Bn | 6.5% | 8% | – |
| Disposable Surgical Devices | $727 Mn | $1.7 Bn | 8.8% | 8% | – |
| Insulin Delivery Devices | $1.3 Bn | $2.8 Bn | 8% | 8% | – |
| Insulin Patch Pumps | $72 Mn | $254 Mn | 13.5% | 8% | – |
| Rehabilitation Equipments | $1.6 Bn | $3.3 Bn | 7.6% | 8% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Adaptogens | $651 Mn | $1.7 Bn | 10% | 8% | – |
| Amino Acid | – | – | – | – | – |
| Anthelmintic Drug | – | – | – | – | – |
| Antioxidants | – | – | – | – | – |
| Antipyretics OTC | – | – | – | – | – |
| BCAA Supplement | $113 Mn | $248 Mn | 8.2% | 8% | – |
| Beauty Supplements | $330 Mn | $911 Mn | 10.7% | 8% | – |
| Biotin Supplement | $32 Mn | $60 Mn | 6.5% | 8.1% | – |
| Bone & Joint Health Supplements | $965 Mn | $2.1 Bn | 7.9% | 8% | – |
| Calcium Supplements | $201 Mn | $414 Mn | 7.5% | 8% | – |
| Cannabidiol (CBD) Supplements | $426 Mn | $2.3 Bn | 18.3% | 8% | – |
| Cardiovascular Health Supplements | $547 Mn | $1.1 Bn | 7.2% | 8% | – |
| Clinical Nutrition | $2.3 Bn | $5.2 Bn | 8.6% | 8% | – |
| Coenzyme Q10 | $40 Mn | $109 Mn | 10.5% | 8% | – |
| Collagen Supplements | $177 Mn | $368 Mn | 7.6% | 8% | – |
| Creatine | $48 Mn | $102 Mn | 7.8% | 8% | – |
| Dietary Supplements | $24.8 Bn | $52 Bn | 7.7% | 8% | – |
| Eye Health Supplements | $249 Mn | $523 Mn | 7.7% | 8% | – |
| Functional Food | $22.9 Bn | $50.4 Bn | 8.2% | 8% | – |
| Hair Growth Supplements | $145 Mn | $336 Mn | 8.8% | 8% | – |
| Herbal Supplements | $6.6 Bn | $15.7 Bn | 9.1% | 8% | – |
| Immune Health Supplement | – | – | – | – | – |
| Iron Supplement | $161 Mn | $347 Mn | 8% | 8% | – |
| Men's Health Supplements | $1.5 Bn | $3.2 Bn | 8.3% | 8% | – |
| Mood and Stress Supplements | $844 Mn | $2.1 Bn | 9.6% | 8% | – |
| Nutritional Supplements | $30.9 Bn | $68.7 Bn | 8.3% | 8% | – |
| Omega 3 Fatty Acid | $330 Mn | $773 Mn | 8.9% | 8% | – |
| Oncology Nutrition | $169 Mn | $392 Mn | 8.8% | 8% | – |
| Osteoporosis Supplements | $249 Mn | $538 Mn | 8% | 8% | – |
| Over The Counter (OTC) Analgesics | $1.8 Bn | $2.9 Bn | 4.9% | 8% | – |
| Over The Counter (OTC) Antifungal | $201 Mn | $337 Mn | 5.3% | 8% | – |
| Over The Counter (OTC) Consumer | $12.1 Bn | $23.2 Bn | 6.7% | 8% | – |
| Over The Counter (OTC) Drugs | $14.3 Bn | $26.1 Bn | 6.2% | 8% | – |
| Over The Counter (OTC) Gastrointestinal Drugs | $450 Mn | $762 Mn | 5.4% | 8% | – |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | $1.2 Bn | $2 Bn | 5.6% | 8% | – |
| Over The Counter (OTC) Ophthalmic Drugs | $289 Mn | $518 Mn | 6% | 8% | – |
| Over The Counter (OTC) Pharmaceuticals | $14.3 Bn | $26.1 Bn | 6.2% | 8% | – |
| Over The Counter (OTC) Sleep Aid Products | $426 Mn | $728 Mn | 5.5% | 8% | – |
| Over The Counter (OTC) Vitamins and Minerals | $2.6 Bn | $5.1 Bn | 7% | 8% | – |
| Plant-Based Supplements | $989 Mn | $2.5 Bn | 9.5% | 8% | – |
| Prebiotics | $651 Mn | $2.3 Bn | 13.3% | 8% | – |
| Probiotic Supplements for Gut Health | $490 Mn | $1.1 Bn | 8.7% | 8% | – |
| Protein Supplement | $1.6 Bn | $3.8 Bn | 8.9% | 8% | – |
| Sports Nutrition | $4.2 Bn | $10.3 Bn | 9.4% | 8% | – |
| Vitamin B12(Cobalamin) | $24 Mn | $47 Mn | 7% | 8% | – |
| Vitamin D Supplements | – | – | – | – | – |
| Weight Management Supplement | – | – | – | – | – |
| Women's Health Supplements | $1.6 Bn | $3.6 Bn | 8.3% | 8% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Abuse Deterrent Opioids | – | – | – | – | – |
| Alexipharmic Drugs | – | – | – | – | – |
| Alopecia Drugs (Hair Loss) | – | – | – | – | – |
| Alzheimer Drugs | $403 Mn | $894 Mn | 8.3% | – | – |
| Aminoglycosides | – | – | – | – | – |
| Anemia Drugs | – | – | – | – | – |
| Anti-Aging | $7.1 Bn | $17.7 Bn | 9.6% | 8% | – |
| Anti-Depressants Drugs | $1.4 Bn | $2.2 Bn | 4.2% | 8% | – |
| Anti-Nerve Growth Factor | – | – | – | – | – |
| Anti-Venom | – | – | – | – | – |
| Anticoagulants | – | – | – | – | – |
| Antithrombotic Drugs | – | – | – | – | – |
| Artificial Skin | $201 Mn | $407 Mn | 7.3% | 8% | – |
| Asthma & COPD Drugs | $4 Bn | $6.8 Bn | 5.5% | 8% | – |
| Atherosclerosis Drugs | – | – | – | – | – |
| Atopic Dermatitis Drugs | $903 Mn | $3.3 Bn | 13.7% | 8% | – |
| Autologous Matrix-induced Chondrogenesis | – | – | – | – | – |
| Axial Spondyloarthritis (axSpA) | – | – | – | – | – |
| Biological Safety Testing | – | – | – | – | – |
| Biosimilar Monoclonal Antibodies | – | – | – | – | – |
| Biosimilars | $3 Bn | $30.9 Bn | 26.4% | 8% | – |
| Blood Plasma | – | – | – | – | – |
| Bone Marrow Aspirate Concentrates | – | – | – | – | – |
| Burn Care | – | – | – | – | – |
| Burn Ointment | – | – | – | – | – |
| Cancer Supportive Care Drugs | $2 Bn | $3.6 Bn | 6.2% | 8% | – |
| Cannabidiol (CBD) | $1.8 Bn | $9.5 Bn | 18.3% | 8% | – |
| Cannabis | $2.7 Bn | $11 Bn | 15% | 8% | – |
| Cell Based Immunotherapy | $1.3 Bn | $11.9 Bn | 24.5% | 8% | – |
| Contraceptives Drugs | $2 Bn | $4.5 Bn | 8.3% | 8% | – |
| Cord Blood Banking Service | $153 Mn | $330 Mn | 8% | 8% | – |
| Diabetes Management | $6.3 Bn | $14.3 Bn | 8.6% | 8% | – |
| Diabetic Retinopathy Drugs | $868 Mn | $1.8 Bn | 7.5% | 8% | – |
| Epilepsy Drugs | $772 Mn | $1.3 Bn | 5% | 8% | – |
| Gastroesophageal Reflux Disease (GERD) Drugs | $418 Mn | $595 Mn | 3.6% | 8% | – |
| Gastrointestinal Drugs | $4.3 Bn | $7.8 Bn | 6.1% | 8% | – |
| HIV Drugs | $2.4 Bn | $4.9 Bn | 7.3% | 8% | – |
| Oncology/Cancer Drugs | $14.2 Bn | $36.6 Bn | 9.9% | 8% | – |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.